131 related articles for article (PubMed ID: 32474846)
21. Tall cell variant of papillary breast carcinoma: an additional case with review of the literature.
Pitino A; Squillaci S; Spairani C; Rassu PC; Cosimi MF
Pathologica; 2017 Sep; 109(3):162-167. PubMed ID: 29154377
[TBL] [Abstract][Full Text] [Related]
22. Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers.
Lee S; Kim HY; Jung YJ; Jung CS; Im D; Kim JY; Lee SM; Oh SH
Curr Probl Cancer; 2022 Apr; 46(2):100843. PubMed ID: 35180531
[TBL] [Abstract][Full Text] [Related]
23. Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.
Yi Z; Ma F; Liu B; Guan X; Li L; Li C; Qian H; Xu B
BMC Cancer; 2019 May; 19(1):442. PubMed ID: 31088410
[TBL] [Abstract][Full Text] [Related]
24. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.
Rothé F; Laes JF; Lambrechts D; Smeets D; Vincent D; Maetens M; Fumagalli D; Michiels S; Drisis S; Moerman C; Detiffe JP; Larsimont D; Awada A; Piccart M; Sotiriou C; Ignatiadis M
Ann Oncol; 2014 Oct; 25(10):1959-1965. PubMed ID: 25185240
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.
Huang CC; Tsai YF; Liu CY; Chao TC; Lien PJ; Lin YS; Feng CJ; Chiu JH; Hsu CY; Tseng LM
BMC Cancer; 2021 Feb; 21(1):199. PubMed ID: 33632156
[TBL] [Abstract][Full Text] [Related]
26. Changing the term "breast tumor resembling the tall cell variant of papillary thyroid carcinoma" to "tall cell variant of papillary breast carcinoma".
Masood S; Davis C; Kubik MJ
Adv Anat Pathol; 2012 Mar; 19(2):108-10. PubMed ID: 22313838
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.
Zhai J; Giannini G; Ewalt MD; Zhang EY; Invernizzi M; Niland J; Lai LL
Hum Pathol; 2019 Apr; 86():85-92. PubMed ID: 30537493
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.
Cheng J; Fu S; Wei C; Tania M; Khan MA; Imani S; Zhou B; Chen H; Xiao X; Wu J; Fu J
Cancer Biomark; 2017; 19(1):85-92. PubMed ID: 28269754
[TBL] [Abstract][Full Text] [Related]
29. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations.
Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK
Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600
[TBL] [Abstract][Full Text] [Related]
30. Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers.
Yang L; Ye F; Bao L; Zhou X; Wang Z; Hu P; Ouyang N; Li X; Shi Y; Chen G; Xia P; Chui M; Li W; Jia Y; Liu Y; Liu J; Ye J; Zhang Z; Bu H
Cancer Sci; 2019 Apr; 110(4):1389-1400. PubMed ID: 30776175
[TBL] [Abstract][Full Text] [Related]
31. Biphasic papillary and lobular breast carcinoma with PIK3CA and IDH1 mutations.
Ang D; VanSandt AM; Beadling C; Warrick A; West RB; Corless CL; Troxell ML
Diagn Mol Pathol; 2012 Dec; 21(4):221-4. PubMed ID: 23111200
[TBL] [Abstract][Full Text] [Related]
32. Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.
Thulin A; Andersson C; Werner Rönnerman E; De Lara S; Chamalidou C; Schoenfeld A; Kovács A; Fagman H; Enlund F; Linderholm BK
Sci Rep; 2021 Dec; 11(1):23548. PubMed ID: 34876602
[TBL] [Abstract][Full Text] [Related]
33. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.
McCullar B; Pandey M; Yaghmour G; Hare F; Patel K; Stein K; Feldman R; Chandler JC; Martin MG
Breast Cancer Res Treat; 2016 Jul; 158(1):195-202. PubMed ID: 27329168
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast Carcinomas.
Lambert A; Salleron J; Lion M; Rouyer M; Lozano N; Leroux A; Merlin JL; Harlé A
Pathol Oncol Res; 2019 Jul; 25(3):1117-1123. PubMed ID: 30426328
[TBL] [Abstract][Full Text] [Related]
35. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
36. An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma.
Colella R; Guerriero A; Giansanti M; Sidoni A; Bellezza G
Int J Surg Pathol; 2015 May; 23(3):217-20. PubMed ID: 24868004
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
38. PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
Guo S; Loibl S; von Minckwitz G; Darb-Esfahani S; Lederer B; Denkert C
Cancer Res Treat; 2020 Jul; 52(3):689-696. PubMed ID: 32019278
[TBL] [Abstract][Full Text] [Related]
39. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing of Breast Cancer in the Neoadjuvant Setting.
Mesquita A; Ferro A; Machado JC; Schmitt F
Pathobiology; 2024; 91(2):114-120. PubMed ID: 37660687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
